Shilpa Medicare Limited
NSE: SHILPAMED · Healthcare
₹861.55
+5.75 (+0.67%)
Last close · 30 Aug 2026, 11:54 am IST
- Open
- ₹859.00
- Day high
- ₹869.00
- Day low
- ₹835.50
- Volume
- 12.01 L
- Prev close
- ₹855.80
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 11,856 Cr
- Price
- 606.20
- P/E (TTM)
- 48.77
- P/E (Fwd)
- 32.77
- P/B
- 4.58
- EV/EBITDA
- 28.69
- EV/Revenue
- 8.11
- PEG
- —
- Div Yield
- 0.08%
- 52W High
- 650.00
- 52W Low
- 259.50
- Beta
- 0.20
Profitability & income
- Revenue (TTM)
- 1,539 Cr
- Net Income (TTM)
- 243 Cr
- EBITDA
- 435 Cr
- Gross Margin
- 70.08%
- Op. Margin
- 20.39%
- Net Margin
- 15.81%
- ROE
- 9.82%
- ROA
- 5.61%
- EPS (TTM)
- 12.43
- EPS (Fwd)
- 18.50
Financial health
- Total Debt
- 660 Cr
- Total Cash
- 45 Cr
- Debt/Equity
- 25.47
- Current Ratio
- 1.31
- Quick Ratio
- 0.68
- Book Value
- 132.46
- Free Cash Flow
- -142 Cr
- Op. Cash Flow
- 342 Cr
Growth
- Revenue Growth
- 31.50%
- Earnings Growth
- 644.60%
- Earnings QoQ
- 642.90%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 437 Cr | 108 Cr | 165 Cr | 106 Cr | 295 Cr | — | 660 Cr | 2,591 Cr |
| 2025-12-31 | 410 Cr | 45 Cr | 102 Cr | 84 Cr | 276 Cr | — | — | — |
| 2025-09-30 | 370 Cr | 44 Cr | 110 Cr | 78 Cr | 264 Cr | — | 593 Cr | 2,437 Cr |
| 2025-06-30 | 321 Cr | 47 Cr | 97 Cr | 63 Cr | 242 Cr | — | — | — |
| 2025-03-31 | 331 Cr | 15 Cr | 59 Cr | 65 Cr | 226 Cr | — | 588 Cr | 2,372 Cr |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1,539 Cr | 243 Cr | 535 Cr | 376 Cr | 1,078 Cr | 342 Cr | 660 Cr | 2,591 Cr |
| 2025-03-31 | 1,286 Cr | 78 Cr | 348 Cr | 244 Cr | 876 Cr | 132 Cr | 588 Cr | 2,363 Cr |
| 2024-03-31 | 1,152 Cr | 32 Cr | 246 Cr | 134 Cr | 743 Cr | 137 Cr | 937 Cr | 1,801 Cr |
| 2023-03-31 | 1,043 Cr | -33 Cr | 113 Cr | -5 Cr | 627 Cr | 180 Cr | 798 Cr | 1,783 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for SHILPAMED?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in